Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
…, J Rosain, E Catherinot, A Willmore, AM Mitchell… - Science …, 2023 - science.org
Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning
antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting …
antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting …
No significant difference in viral load between vaccinated and unvaccinated, asymptomatic and symptomatic groups when infected with SARS-CoV-2 delta variant
CB Acharya, J Schrom, AM Mitchell, DA Coil… - MedRxiv, 2021 - medrxiv.org
We found no significant difference in cycle threshold values between vaccinated and
unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the …
unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the …
Viral load among vaccinated and unvaccinated, asymptomatic and symptomatic persons infected with the SARS-CoV-2 delta variant
CB Acharya, J Schrom, AM Mitchell… - Open forum …, 2022 - academic.oup.com
We found no significant difference in cycle threshold values between vaccinated and unvaccinated
persons infected with severe acute respiratory syndrome coronavirus 2 Delta, overall …
persons infected with severe acute respiratory syndrome coronavirus 2 Delta, overall …
SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron
…, J Peng, D Black, AM Mitchell… - The Journal of …, 2022 - academic.oup.com
The wide spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants with phenotypes impacting transmission and antibody sensitivity necessitates …
variants with phenotypes impacting transmission and antibody sensitivity necessitates …
Estimation of secondary household attack rates for emergent spike L452R severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants detected by …
Background Sequencing of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
viral genome from patient samples is an important epidemiological tool for monitoring …
viral genome from patient samples is an important epidemiological tool for monitoring …
[HTML][HTML] Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in …
Background. Sequencing of the SARS-CoV-2 viral genome from patient samples is an
important epidemiological tool for monitoring and responding to the pandemic, including the …
important epidemiological tool for monitoring and responding to the pandemic, including the …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics and Immune Responses in a Household of Vaccinated Persons
…, AM Mitchell, M Hapte-Selassie… - Clinical Infectious …, 2022 - academic.oup.com
While SARS-CoV-2 vaccines prevent severe disease effectively, postvaccination “breakthrough”
COVID-19 infections and transmission among vaccinated individuals remain ongoing …
COVID-19 infections and transmission among vaccinated individuals remain ongoing …
[HTML][HTML] Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
…, C Marquez, CY Wang, A Saxena, AM Mitchell… - PloS one, 2023 - journals.plos.org
COVID-19 oral treatments require initiation within 5 days of symptom onset. Although antigen
tests are less sensitive than RT-PCR, rapid results could facilitate entry to treatment. We …
tests are less sensitive than RT-PCR, rapid results could facilitate entry to treatment. We …
Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains
… Matthew T Laurie; Jamin Liu; Sara Sunshine; James Peng; Douglas Black; Anthea M
Mitchell; Sabrina A Mann; Genay Pilarowski; Kelsey C Zorn; Luis Rubio; Sara Bravo; …
Mitchell; Sabrina A Mann; Genay Pilarowski; Kelsey C Zorn; Luis Rubio; Sara Bravo; …
[PDF][PDF] Joint Authors for Correspondence: Diane Havlir, Richard Michelmore
CB Acharya, J Schrom, AM Mitchell, DA Coil… - dibellainsieme.org
We found no significant difference in cycle threshold values between vaccinated and
unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the …
unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the …
